Cargando…
Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
The development of resistance to anti-cancer therapeutics remains one of the core issues preventing the improvement of survival rates in cancer. Therapy resistance can arise in a multitude of ways, including the accumulation of epigenetic alterations in cancer cells. By remodeling DNA methylation pa...
Autores principales: | Quagliano, Anthony, Gopalakrishnapillai, Anilkumar, Barwe, Sonali P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326773/ https://www.ncbi.nlm.nih.gov/pubmed/32670880 http://dx.doi.org/10.3389/fonc.2020.00992 |
Ejemplares similares
-
Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies
por: Quagliano, Anthony, et al.
Publicado: (2023) -
Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014) -
Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016) -
Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
por: Barwe, Sonali P., et al.
Publicado: (2020) -
Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies
por: Sidhu, Ishnoor, et al.
Publicado: (2021)